US, UK approvals not a priority for Russia COVID-19 vaccine Sputnik V - Business Insider

  • 📰 BusinessInsider
  • ⏱ Reading Time:
  • 64 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 29%
  • Publisher: 51%

日本 ニュース ニュース

日本 最新ニュース,日本 見出し

The lead of Russia's COVID-19 vaccine program says the shot won't be available in the US or UK any time soon

In the UK, Dmitriev said applying for approval will depend on succeeding with

a planned trial that uses Sputnik V in combination with a vaccine developed by AstraZeneca and the University of Oxford"If that shows high level of efficacy, we will be happy to approach the UK with that, obviously jointly with AstraZeneca," he said. That study will take months to run, and before that point Dmitriev said Russia will not apply for UK authorization.A new vaccine is on display at the Nikolai Gamaleya National Center of Epidemiology and Microbiology in Moscow, Russia on Thursday, Aug. 6, 2020.Russia has already reached a handful of supply deals with other countries, none of them major Western powers.

"For now, we are focused on markets that look at who we are on the merit of data, on the merit of our platform," Dmitriev said,"and obviously something with UK, something with Europe, something with US would have major political overtones not from us but from them." Sixteen foreign countries or sovereign states have already OK'd Russia's shot: Belarus, Argentina, Bolivia, Serbia, Algeria, Palestine, Venezuela, Paraguay, Turkmenistan, Hungary, United Arab Emirates, Iran, Guinea, and Tunisia. Dmitriev said he expects Sputnik V to be registered in 25 nations by the end of next week.

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

 /  🏆 729. in JP
 

コメントありがとうございます。コメントは審査後に公開されます。

No free lunch.

Considering it was hacked from the US and UK or simply given to them by a insider

I’m good with that.

To be honest, if I were told the shot were from Russia, I would pass anyway.

日本 最新ニュース, 日本 見出し